Any changes to law on human gene editing should be after public consultation
By Peter McKnight,
Vancouver Sun
| 12. 08. 2022
When a scientist announces the opening of a new laboratory, it doesn’t ordinarily make news around the world. But Chinese biophysicist He Jiankui is no ordinary scientist.
He’s announcement at the end of November came just seven months after he completed a three-year prison sentence for practising medicine illegally. At issue was He’s 2018 YouTube announcement that he had created the world’s first gene-edited babies.
As details became clear, scientists and lawmakers inside and outside China condemned He’s actions, and he was ultimately fired, fined and sentenced to prison. Gene editing also received a lot of negative press, with the usual stories about designer babies flooding the media. He’s new announcement could result in a repeat of the hysteria.
Indeed, stories raising the spectre of eugenics led Canada to prohibit human gene editing long before He created his designer babies. He employed a technique known as CRISPR, short for clustered regularly interspaced short palindromic repeats, which acts like a pair of scissors that allows scientists to edit parts of the human genome.
He used CRISPR to edit the genes of...
Related Articles
By Liyan Qi and Jonathan Cheng, The Wall Street Journal | 03.26.2025
photo via Wikimedia Commons licensed under CC by 3.0
Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical guidelines and claimed he had produced genetically modified babies designed to resist HIV infection.
Now, the self-styled ...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
By Michael Gibney, PharmaVoice | 03.20.2025
The death this week of a teenager receiving Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy is a tragic reminder of the stakes involved in cutting-edge biotech innovation.
While gene therapies like Sarepta’s offer an opportunity to treat and...
By Staff, The Medicine Maker | 03.21.2025
"The Promise and Peril of CRISPR" cover by Johns Hopkins University Press
As a paediatrician taking care of children with sickle cell disease, Neal Baer, a Harvard Medical School graduate, was in awe of the power of CRISPR technologies. Later...